Drugs / SMOF
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT06316362 Comparator | Jan 2022 → Feb 2023 | poisoning | Alexandria University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SMOF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06316362 ↗ |
| Modality | Other / unclassified | “new lipid emulsion product” NCT06316362 ↗ |